Treatment with an anti-Dkk1 antibody, after engraftment of Dkk1 expressing primary MM cells, resulted in a reduced number of osteoclasts, enhanced number of osteoblasts, decreased bone resorption, and a subsequent decrease in tumor burden [77]. This evidence concerns the gene DKK1 and neoplasm.